Semi-quantitative detection of SMN1 exon 7 by real-time PCR, used in NBS for SMA due to the homozygous deletion of exon 7, is a genetic screening method with a theoretical PPV of 100%. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.